Mitchell Chan, Director of Avalo Therapeutics AVTX, has filed 0 purchases and 1 sale on the open market. Over the past 12 months that comes to a net sale of $72.5K. The latest trade was on 05/06.

MC

MC

Mitchell Chan

Director

Company

Avalo Therapeutics AVTX

First filing

23/12/21

Trades

15 trades

Buys / sales

0 / 1

12-month net buying

−$72.5K

Last trade

05/06

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Avalo TherapeuticsAVTX	Open-market sale10b5-1 plan	05/06	05/07	3,167 sh	$22.88	$72,460.96	−50.0%